{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:34:05Z","timestamp":1780461245521,"version":"3.54.1"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12013-024-01424-4","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:02:21Z","timestamp":1721901741000},"page":"3053-3069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent Advances in Immunological Landscape and Immunotherapeutic Agent of Nipah Virus Infection"],"prefix":"10.1007","volume":"82","author":[{"given":"Chiranjib","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojit","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"issue":"7982","key":"1424_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/d41586-023-03162-8","volume":"622","author":"TS Anish","year":"2023","unstructured":"Anish, T. S. (2023). Nipah virus is deadly - but smart policy changes can help quell pandemic risk. Nature, 622(7982), 219.","journal-title":"Nature"},{"key":"1424_CR2","doi-asserted-by":"crossref","unstructured":"Gomez Roman, R. et al. (2020) Nipah@20: Lessons learned from another virus with pandemic potential. mSphere, 5(4), e00602-20.","DOI":"10.1128\/msphere.00602-20"},{"issue":"2","key":"1424_CR3","first-page":"117","volume":"27","author":"RK Ochani","year":"2019","unstructured":"Ochani, R. K. et al. (2019). Nipah virus - the rising epidemic: a review. Infez Med, 27(2), 117\u2013127.","journal-title":"Infez Med"},{"issue":"1","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/01652176.2019.1580827","volume":"39","author":"RK Singh","year":"2019","unstructured":"Singh, R. K. et al. (2019). Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review. Vet Q, 39(1), 26\u201355.","journal-title":"Vet Q"},{"issue":"4","key":"1424_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.7861\/clinmed.2022-0166","volume":"22","author":"AM Alam","year":"2022","unstructured":"Alam, A. M. (2022). Nipah virus, an emerging zoonotic disease causing fatal encephalitis. Clin Med, 22(4), 348\u2013352.","journal-title":"Clin Med"},{"issue":"Suppl 1","key":"1424_CR6","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.4103\/jpbs.jpbs_935_23","volume":"16","author":"N Suman","year":"2024","unstructured":"Suman, N. et al. (2024). NIPAH Virus Encephalitis: Unveiling the epidemiology, risk factors, and clinical outcomes - a systematic review and meta-analysis. J Pharm Bioallied Sci, 16(Suppl 1), S102\u2013S105.","journal-title":"J Pharm Bioallied Sci"},{"issue":"4","key":"1424_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11908-008-0051-6","volume":"10","author":"CT Tan","year":"2008","unstructured":"Tan, C. T., & Chua, K. B. (2008). Nipah virus encephalitis. Curr Infect Dis Rep., 10(4), 315\u2013320.","journal-title":"Curr Infect Dis Rep."},{"key":"1424_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1113\/jphysiol.1979.sp012870","volume":"292","author":"S Rotshenker","year":"1979","unstructured":"Rotshenker, S. (1979). Synapse formation in intact innervated cutaneous-pectoris muscles of the frog following denervation of the opposite muscle. J Physiol, 292, 535\u2013547.","journal-title":"J Physiol"},{"issue":"6","key":"1424_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12828","volume":"48","author":"KC Ong","year":"2022","unstructured":"Ong, K. C. et al. (2022). Neuronal infection is a major pathogenetic mechanism and cause of fatalities in human acute Nipah virus encephalitis. Neuropathol Appl Neurobiol, 48(6), e12828.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"1424_CR10","first-page":"2143","volume":"63","author":"P Kitsutani","year":"2005","unstructured":"Kitsutani, P., & Ohta, M. (2005). [Nipah virus infections]. Nihon Rinsho, 63(12), 2143\u20132153.","journal-title":"Nihon Rinsho"},{"issue":"7049","key":"1424_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature03838","volume":"436","author":"OA Negrete","year":"2005","unstructured":"Negrete, O. A. et al. (2005). EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature, 436(7049), 401\u2013405.","journal-title":"Nature"},{"issue":"6","key":"1424_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/1995-7645.281613","volume":"13","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty, C. et al. (2020). The 2019 novel coronavirus disease (COVID-19) pandemic: a zoonotic prospective. Asian Pac J Trop Med, 13(6), 242\u2013246.","journal-title":"Asian Pac J Trop Med"},{"key":"1424_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.coviro.2018.12.007","volume":"34","author":"LF Wang","year":"2019","unstructured":"Wang, L. F., & Anderson, D. E. (2019). Viruses in bats and potential spillover to animals and humans. Curr Opin Virol, 34, 79\u201389.","journal-title":"Curr Opin Virol"},{"issue":"8","key":"1424_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41579-020-0394-z","volume":"18","author":"M Letko","year":"2020","unstructured":"Letko, M. et al. (2020). Bat-borne virus diversity, spillover and emergence. Nat Rev Microbiol, 18(8), 461\u2013471.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1424_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s13149-015-0448-z","volume":"108","author":"F Rodhain","year":"2015","unstructured":"Rodhain, F. (2015). Bats and Viruses: complex relationships. Bull Soc Pathol Exot, 108(4), 272\u2013289.","journal-title":"Bull Soc Pathol Exot"},{"issue":"8","key":"1424_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3201\/eid1408.071492","volume":"14","author":"JH Epstein","year":"2008","unstructured":"Epstein, J. H. et al. (2008). Henipavirus infection in fruit bats (Pteropus giganteus), India. Emerg Infect Dis, 14(8), 1309\u20131311.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"1424_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1286-4579(01)01522-2","volume":"4","author":"KB Chua","year":"2002","unstructured":"Chua, K. B. et al. (2002). Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect, 4(2), 145\u2013151.","journal-title":"Microbes Infect"},{"issue":"9","key":"1424_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00705-012-1352-5","volume":"157","author":"J Prescott","year":"2012","unstructured":"Prescott, J. et al. (2012). The immune response to Nipah virus infection. Arch Virol, 157(9), 1635\u20131641.","journal-title":"Arch Virol"},{"key":"1424_CR19","doi-asserted-by":"crossref","unstructured":"Brasier, A. R., A. Garc\u00eda-Sastre, and S. M. Lemon, Cellular signaling and innate immune responses to RNA virus infections2009: ASM Press","DOI":"10.1128\/9781555815561"},{"issue":"5","key":"1424_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cimid.2007.11.002","volume":"32","author":"Jr,JF Wellehan","year":"2009","unstructured":"Wellehan, Jr, J. F. et al. (2009). Detection of specific antibody responses to vaccination in variable flying foxes (Pteropus hypomelanus). Comp Immunol Microbiol Infect Dis, 32(5), 379\u2013394.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"1424_CR21","first-page":"2017","volume":"8","author":"T Schountz","year":"1098","unstructured":"Schountz, T. et al. (1098). Immunological control of viral infections in bats and the emergence of viruses highly pathogenic to humans. Front Immunol, 8, 2017.","journal-title":"Front Immunol"},{"issue":"2","key":"1424_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/path.4444","volume":"235","author":"E de Wit","year":"2015","unstructured":"de Wit, E., & Munster, V. J. (2015). Animal models of disease shed light on Nipah virus pathogenesis and transmission. J Pathol, 235(2), 196\u2013205.","journal-title":"J Pathol"},{"issue":"5","key":"1424_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.4269\/ajtmh.2011.10-0567","volume":"85","author":"K Halpin","year":"2011","unstructured":"Halpin, K. et al. (2011). Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg, 85(5), 946\u2013951.","journal-title":"Am J Trop Med Hyg"},{"key":"1424_CR24","first-page":"123","volume":"359","author":"CF Basler","year":"2012","unstructured":"Basler, C. F. (2012). Nipah and Hendra virus interactions with the innate immune system. Curr Top Microbiol Immunol, 359, 123\u2013152.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"15","key":"1424_CR25","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.1128\/JVI.00302-15","volume":"89","author":"NB Glennon","year":"2015","unstructured":"Glennon, N. B. et al. (2015). Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions. J Virol, 89(15), 7550\u20137566.","journal-title":"J Virol"},{"issue":"10","key":"1424_CR26","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.1518240113","volume":"113","author":"P Zhou","year":"2016","unstructured":"Zhou, P. et al. (2016). Contraction of the type I IFN locus and unusual constitutive expression of IFN-alpha in bats. Proc Natl Acad Sci USA, 113(10), 2696\u20132701.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1424_CR27","doi-asserted-by":"publisher","first-page":"e25385","DOI":"10.1371\/journal.pone.0025385","volume":"6","author":"P Zhou","year":"2011","unstructured":"Zhou, P. et al. (2011). Type III IFN receptor expression and functional characterisation in the pteropid bat, Pteropus alecto. PLoS One, 6(9), e25385.","journal-title":"PLoS One"},{"issue":"5","key":"1424_CR28","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.4049\/jimmunol.1003115","volume":"186","author":"P Zhou","year":"2011","unstructured":"Zhou, P. et al. (2011). Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. J Immunol, 186(5), 3138\u20133147.","journal-title":"J Immunol"},{"issue":"1","key":"1424_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25815-9","volume":"8","author":"S Uchida","year":"2018","unstructured":"Uchida, S. et al. (2018). Possible role of the Nipah virus V protein in the regulation of the interferon beta induction by interacting with UBX domain-containing protein1. Sci Rep., 8(1), 7682.","journal-title":"Sci Rep."},{"key":"1424_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105693","volume":"170","author":"P Devnath","year":"2022","unstructured":"Devnath, P. et al. (2022). The pathogenesis of Nipah virus: A review. Microb Pathogen, 170, 105693.","journal-title":"Microb Pathogen"},{"issue":"10","key":"1424_CR31","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1099\/jgv.0.000934","volume":"98","author":"L Sauerhering","year":"2017","unstructured":"Sauerhering, L. et al. (2017). Variability of interferon-\u03bb induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors. J Gen Virol, 98(10), 2447\u20132453.","journal-title":"J Gen Virol"},{"key":"1424_CR32","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/v15112147","volume":"15","author":"S van Tol","year":"2023","unstructured":"van Tol, S. et al. (2023). Pteropus vampyrus TRIM40 is an Interferon-stimulated gene that antagonizes RIG-I-like receptors. Viruses, 15, 2147 1125.","journal-title":"Viruses"},{"key":"1424_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1156758","volume":"14","author":"B Escudero-P\u00e9rez","year":"2023","unstructured":"Escudero-P\u00e9rez, B. et al. (2023). Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection. Front Immunol, 14, 1156758.","journal-title":"Front Immunol"},{"issue":"2","key":"1424_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.virol.2012.06.001","volume":"432","author":"D Kong","year":"2012","unstructured":"Kong, D. et al. (2012). Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology, 432(2), 327\u2013335.","journal-title":"Virology"},{"key":"1424_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0109-5","volume":"4","author":"R Keshwara","year":"2019","unstructured":"Keshwara, R. et al. (2019). Rabies-based vaccine induces potent immune responses against Nipah virus. NPJ Vaccines, 4, 15.","journal-title":"NPJ Vaccines"},{"issue":"22","key":"1424_CR36","doi-asserted-by":"publisher","first-page":"11476","DOI":"10.1128\/JVI.76.22.11476-11483.2002","volume":"76","author":"JJ Rodriguez","year":"2002","unstructured":"Rodriguez, J. J. et al. (2002). Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol, 76(22), 11476\u201311483.","journal-title":"J Virol"},{"issue":"6","key":"1424_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00449-20","volume":"5","author":"TR Keiffer","year":"2020","unstructured":"Keiffer, T. R. et al. (2020). Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors. mSphere, 5(6), e00449-20.","journal-title":"mSphere"},{"key":"1424_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-4-54","volume":"4","author":"L-Y Chang","year":"2007","unstructured":"Chang, L.-Y. et al. (2007). Human neuronal cell protein responses to Nipah virus infection. Virol J, 4, 54.","journal-title":"Virol J"},{"issue":"2","key":"1424_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/0882824041310568","volume":"17","author":"JJ Rodriguez","year":"2004","unstructured":"Rodriguez, J. J., & Horvath, C. M. (2004). Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. Viral Immunol, 17(2), 210\u2013219.","journal-title":"Viral Immunol"},{"key":"1424_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coviro.2020.07.003","volume":"44","author":"C Diaz-Salazar","year":"2020","unstructured":"Diaz-Salazar, C., & Sun, J. C. (2020). Natural killer cell responses to emerging viruses of zoonotic origin. Curr Opin Virol, 44, 97\u2013111.","journal-title":"Curr Opin Virol"},{"issue":"6","key":"1424_CR41","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/microorganisms10061162","volume":"10","author":"YJM Liew","year":"2022","unstructured":"Liew, Y. J. M. et al. (2022). The immunobiology of Nipah virus. Microorganisms, 10(6), 1162.","journal-title":"Microorganisms"},{"issue":"1","key":"1424_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li, D., & Wu, M. (2021). Pattern recognition receptors in health and diseases. Signal Transduct Target Ther, 6(1), 291.","journal-title":"Signal Transduct Target Ther"},{"key":"1424_CR43","doi-asserted-by":"publisher","first-page":"121940","DOI":"10.1016\/j.lfs.2023.121940","volume":"329","author":"A Isazadeh","year":"2023","unstructured":"Isazadeh, A. et al. (2023). Pattern-recognition receptors (PRRs) in SARS-CoV-2. Life Sci, 329, 121940.","journal-title":"Life Sci"},{"key":"1424_CR44","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.meegid.2020.104587","volume":"85","author":"M Bhattacharya","year":"2020","unstructured":"Bhattacharya, M. et al. (2020). Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4\/MD-2 complex. Infect Genet Evol, 85, 104587.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"1424_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2023.100347","volume":"22","author":"C Chakraborty","year":"2024","unstructured":"Chakraborty, C. et al. (2024). SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4\/MD2 compared to other variants. J Genet Eng Biotechnol, 22(1), 100347.","journal-title":"J Genet Eng Biotechnol"},{"issue":"2","key":"1424_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cr.7310019","volume":"16","author":"RB Seth","year":"2006","unstructured":"Seth, R. B., Sun, L., & Chen, Z. J. (2006). Antiviral innate immunity pathways. Cell Res, 16(2), 141\u2013147.","journal-title":"Cell Res"},{"issue":"2","key":"1424_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/viro.1996.0259","volume":"219","author":"BL Jacobs","year":"1996","unstructured":"Jacobs, B. L., & Langland, J. O. (1996). When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology, 219(2), 339\u2013349.","journal-title":"Virology"},{"issue":"Pt 10","key":"1424_CR48","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","volume":"81","author":"S Goodbourn","year":"2000","unstructured":"Goodbourn, S., Didcock, L., & Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol, 81(Pt 10), 2341\u20132364.","journal-title":"J Gen Virol"},{"issue":"9","key":"1424_CR49","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1128\/JVI.79.9.5241-5248.2005","volume":"79","author":"KK Conzelmann","year":"2005","unstructured":"Conzelmann, K. K. (2005). Transcriptional activation of alpha\/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J Virol, 79(9), 5241\u20135248.","journal-title":"J Virol"},{"issue":"1","key":"1424_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrmicro1323","volume":"4","author":"BT Eaton","year":"2006","unstructured":"Eaton, B. T. et al. (2006). Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol, 4(1), 23\u201335.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1424_CR51","first-page":"305","volume":"32","author":"E Dardai","year":"1991","unstructured":"Dardai, E., Pirityi, S., & Nagy, L. (1991). Parenteral and enteral nutrition and the enterocutaneous fistula treatment. II. Factors influencing the outcome of treatment. Acta Chir Hung, 32(4), 305\u2013318.","journal-title":"Acta Chir Hung"},{"key":"1424_CR52","doi-asserted-by":"publisher","first-page":"101277","DOI":"10.1016\/j.smim.2019.05.001","volume":"43","author":"S Lukhele","year":"2019","unstructured":"Lukhele, S., Boukhaled, G. M., & Brooks, D. G. (2019). Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin Immunol, 43, 101277.","journal-title":"Semin Immunol"},{"issue":"8","key":"1424_CR53","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1128\/JVI.02599-08","volume":"83","author":"S Kulkarni","year":"2009","unstructured":"Kulkarni, S., Volchkova, V., Basler, C. F., Palese, P., Volchkov, V. E. & Shaw, M. L. (2009). Nipah virus edits its P gene at highfrequency to express the V and W proteins. J. Virol, 83(8), 3982\u20133987. https:\/\/doi.org\/10.1128\/JVI.02599-08.","journal-title":"J. Virol"},{"issue":"21","key":"1424_CR54","doi-asserted-by":"publisher","first-page":"10965","DOI":"10.1128\/JVI.01335-10","volume":"84","author":"J Seto","year":"2010","unstructured":"Seto, J. et al. (2010). Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study. J Virol, 84(21), 10965\u201310973.","journal-title":"J Virol"},{"issue":"22","key":"1424_CR55","doi-asserted-by":"publisher","first-page":"11476","DOI":"10.1128\/JVI.76.22.11476-11483.2002","volume":"76","author":"JJ Rodriguez","year":"2002","unstructured":"Rodriguez, J. J., Parisien, J. P., & Horvath, C. M. (2002). Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol, 76(22), 11476\u201311483.","journal-title":"J Virol"},{"issue":"1","key":"1424_CR56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virol.2010.05.005","volume":"404","author":"MK Lo","year":"2010","unstructured":"Lo, M. K. et al. (2010). Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons. Virology, 404(1), 78\u201388.","journal-title":"Virology"},{"issue":"4","key":"1424_CR57","doi-asserted-by":"publisher","first-page":"e2032","DOI":"10.1371\/journal.pone.0002032","volume":"3","author":"M Habjan","year":"2008","unstructured":"Habjan, M. et al. (2008). Processing of genome 5\u2032 termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One, 3(4), e2032.","journal-title":"PLoS One"},{"issue":"3","key":"1424_CR58","doi-asserted-by":"publisher","first-page":"e0006343","DOI":"10.1371\/journal.pntd.0006343","volume":"12","author":"AJ Leon","year":"2018","unstructured":"Leon, A. J. et al. (2018). Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains. PLoS Neglect Trop Dis, 12(3), e0006343.","journal-title":"PLoS Neglect Trop Dis"},{"issue":"2","key":"1424_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs, T. A. et al. (2007). Novel cell death program leads to neutrophil extracellular traps. J Cell Biol, 176(2), 231\u2013241.","journal-title":"J Cell Biol"},{"issue":"7","key":"1424_CR60","doi-asserted-by":"publisher","first-page":"e22043","DOI":"10.1371\/journal.pone.0022043","volume":"6","author":"S Hemmers","year":"2011","unstructured":"Hemmers, S. et al. (2011). PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One, 6(7), e22043.","journal-title":"PLoS One"},{"issue":"11","key":"1424_CR61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","volume":"30","author":"V Papayannopoulos","year":"2009","unstructured":"Papayannopoulos, V., & Zychlinsky, A. (2009). NETs: a new strategy for using old weapons. Trends Immunol, 30(11), 513\u2013521.","journal-title":"Trends Immunol"},{"key":"1424_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","volume":"23","author":"AW Segal","year":"2005","unstructured":"Segal, A. W. (2005). How neutrophils kill microbes. Annu Rev Immunol, 23, 197\u2013223.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"1424_CR63","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1016\/j.cub.2011.03.021","volume":"21","author":"B Amulic","year":"2011","unstructured":"Amulic, B., & Hayes, G. (2011). Neutrophil extracellular traps. Curr Biol, 21(9), R297\u2013R298.","journal-title":"Curr Biol"},{"issue":"1","key":"1424_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2012.11.002","volume":"171","author":"B Drescher","year":"2013","unstructured":"Drescher, B., & Bai, F. (2013). Neutrophil in viral infections, friend or foe? Virus Res, 171(1), 1\u20137.","journal-title":"Virus Res"},{"key":"1424_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-019-0222-2","volume":"16","author":"P Nied\u017awiedzka-Rystwej","year":"2019","unstructured":"Nied\u017awiedzka-Rystwej, P. et al. (2019). \u201cIn sickness and in health\u201d\u2013how neutrophil extracellular trap (NET) works in infections, selected diseases and pregnancy. J Inflamm, 16, 1\u20138.","journal-title":"J Inflamm"},{"key":"1424_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2016.11.033","volume":"228","author":"JM Agraz-Cibrian","year":"2017","unstructured":"Agraz-Cibrian, J. M. et al. (2017). Understanding the molecular mechanisms of NETs and their role in antiviral innate immunity. Virus Res, 228, 124\u2013133.","journal-title":"Virus Res"},{"issue":"1","key":"1424_CR67","doi-asserted-by":"publisher","first-page":"e1004546","DOI":"10.1371\/journal.ppat.1004546","volume":"11","author":"CN Jenne","year":"2015","unstructured":"Jenne, C. N., & Kubes, P. (2015). Virus-induced NETs-critical component of host defense or pathogenic mediator? PLoS Pathog, 11(1), e1004546.","journal-title":"PLoS Pathog"},{"key":"1424_CR68","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3389\/fimmu.2019.03108","volume":"10","author":"CH Hiroki","year":"2019","unstructured":"Hiroki, C. H. et al. (2019). Neutrophil extracellular traps effectively control acute Chikungunya virus infection. Front Immunol, 10, 3108.","journal-title":"Front Immunol"},{"key":"1424_CR69","doi-asserted-by":"crossref","unstructured":"Liew, Y. J. M. et al. (2022) The immunobiology of Nipah virus. Microorganisms, 10(6), 1162.","DOI":"10.3390\/microorganisms10061162"},{"issue":"1","key":"1424_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","volume":"179","author":"T Narasaraju","year":"2011","unstructured":"Narasaraju, T. et al. (2011). Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol, 179(1), 199\u2013210.","journal-title":"Am J Pathol"},{"issue":"9","key":"1424_CR71","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.2209","volume":"16","author":"V Marcos","year":"2010","unstructured":"Marcos, V. et al. (2010). CXCR2 mediates NADPH oxidase\u2013independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med, 16(9), 1018\u20131023.","journal-title":"Nat Med"},{"key":"1424_CR72","unstructured":"Deleterious, C.-D., (2009). Critical Role of IL-1 Receptor-Associated."},{"key":"1424_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-9-57","volume":"9","author":"MD Tate","year":"2008","unstructured":"Tate, M. D., Brooks, A. G., & Reading, P. C. (2008). The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res, 9, 1\u201313.","journal-title":"Respir Res"},{"issue":"6","key":"1424_CR74","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","volume":"189","author":"MJ Kaplan","year":"2012","unstructured":"Kaplan, M. J., & Radic, M. (2012). Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol, 189(6), 2689\u20132695.","journal-title":"J Immunol"},{"issue":"6","key":"1424_CR75","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1042\/BST20190629","volume":"47","author":"M Euler","year":"2019","unstructured":"Euler, M., & Hoffmann, M. H. (2019). The double-edged role of neutrophil extracellular traps in inflammation. Biochem Soc Trans, 47(6), 1921\u20131930.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"1424_CR76","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/path.4660","volume":"238","author":"B Cortjens","year":"2016","unstructured":"Cortjens, B. et al. (2016). Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease. J Pathol, 238(3), 401\u2013411.","journal-title":"J Pathol"},{"issue":"23","key":"1424_CR77","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1128\/JVI.79.23.14933-14944.2005","volume":"79","author":"TM Tumpey","year":"2005","unstructured":"Tumpey, T. M. et al. (2005). Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol, 79(23), 14933\u201314944.","journal-title":"J Virol"},{"key":"1424_CR78","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fimmu.2016.00366","volume":"7","author":"G Schonrich","year":"2016","unstructured":"Schonrich, G., & Raftery, M. J. (2016). Neutrophil extracellular traps go viral. Front Immunol, 7, 366.","journal-title":"Front Immunol"},{"issue":"1","key":"1424_CR79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.chom.2012.05.015","volume":"12","author":"T Saitoh","year":"2012","unstructured":"Saitoh, T. et al. (2012). Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe, 12(1), 109\u2013116.","journal-title":"Cell Host Microbe"},{"issue":"43","key":"1424_CR80","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.1073\/pnas.0905815106","volume":"106","author":"J Chang","year":"2009","unstructured":"Chang, J., Kunkel, S. L., & Chang, C. H. (2009). Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci USA, 106(43), 18327\u201318332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1424_CR81","first-page":"129","volume":"380","author":"CT Ng","year":"2014","unstructured":"Ng, C. T., & Oldstone, M. B. (2014). IL-10: achieving balance during persistent viral infection. Curr Top Microbiol Immunol, 380, 129\u2013144.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"1424_CR82","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/intimm\/dxv037","volume":"27","author":"P Shen","year":"2015","unstructured":"Shen, P., & Fillatreau, S. (2015). Suppressive functions of B cells in infectious diseases. Int Immunol, 27(10), 513\u2013519.","journal-title":"Int Immunol"},{"issue":"1-2","key":"1424_CR83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1008184330127","volume":"21","author":"M Raftery","year":"2000","unstructured":"Raftery, M., Muller, A., & Schonrich, G. (2000). Herpesvirus homologues of cellular genes. Virus Genes, 21(1-2), 65\u201375.","journal-title":"Virus Genes"},{"issue":"5","key":"1424_CR84","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.4049\/jimmunol.173.5.3383","volume":"173","author":"MJ Raftery","year":"2004","unstructured":"Raftery, M. J. et al. (2004). Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol, 173(5), 3383\u20133391.","journal-title":"J Immunol"},{"issue":"17","key":"1424_CR85","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1128\/JVI.00733-11","volume":"85","author":"X Li","year":"2011","unstructured":"Li, X. et al. (2011). Kaposi\u2019s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65. J Virol, 85(17), 8606\u20138615.","journal-title":"J Virol"},{"key":"1424_CR86","first-page":"219","volume":"253","author":"R Dorries","year":"2001","unstructured":"Dorries, R. (2001). The role of T-cell-mediated mechanisms in virus infections of the nervous system. Curr Top Microbiol Immunol, 253, 219\u2013245.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"1424_CR87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nri3152","volume":"12","author":"SL Swain","year":"2012","unstructured":"Swain, S. L., McKinstry, K. K., & Strutt, T. M. (2012). Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol, 12(2), 136\u2013148.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1424_CR88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. (2023). T cells in health and disease. Signal Transduct Target Ther, 8(1), 235.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"1424_CR89","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh, C. H. et al. (2023). CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med, 55(11), 2287\u20132299.","journal-title":"Exp Mol Med"},{"key":"1424_CR90","doi-asserted-by":"publisher","first-page":"1291796","DOI":"10.3389\/fimmu.2023.1291796","volume":"14","author":"H Lin","year":"2023","unstructured":"Lin, H., Xu, Y., & Lin, C. (2023). Heterogeneity and subtypes of CD4(+) regulatory T cells: implications for tumor therapy. Front Immunol, 14, 1291796.","journal-title":"Front Immunol"},{"issue":"6","key":"1424_CR91","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.tim.2022.12.008","volume":"31","author":"J Yunis","year":"2023","unstructured":"Yunis, J., Short, K. R., & Yu, D. (2023). Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation. Trends Microbiol, 31(6), 644\u2013656.","journal-title":"Trends Microbiol"},{"key":"1424_CR92","doi-asserted-by":"crossref","unstructured":"Kervevan, J. and Chakrabarti, L. A. (2021) Role of CD4+ T cells in the control of viral infections: recent advances and open questions. Int J Mol Sci, 22(2), 523.","DOI":"10.3390\/ijms22020523"},{"issue":"10","key":"1424_CR93","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/cid\/ciz010","volume":"69","author":"G Arunkumar","year":"2019","unstructured":"Arunkumar, G. et al. (2019). Adaptive immune responses in humans during Nipah virus acute and convalescent phases of infection. Clin Infect Dis, 69(10), 1752\u20131756.","journal-title":"Clin Infect Dis"},{"key":"1424_CR94","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijid.2020.05.106","volume":"97","author":"CK Kang","year":"2020","unstructured":"Kang, C. K. et al. (2020). Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis, 97, 313\u2013321.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"1424_CR95","doi-asserted-by":"publisher","first-page":"e0005532","DOI":"10.1371\/journal.pntd.0005532","volume":"11","author":"Y Cong","year":"2017","unstructured":"Cong, Y. et al. (2017). Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus. PLoS Negl Trop Dis, 11(4), e0005532.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1424_CR96","doi-asserted-by":"publisher","first-page":"e0007454","DOI":"10.1371\/journal.pntd.0007454","volume":"13","author":"A Lara","year":"2019","unstructured":"Lara, A. et al. (2019). Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol. PLoS Negl Trop Dis, 13(6), e0007454.","journal-title":"PLoS Negl Trop Dis"},{"issue":"40","key":"1424_CR97","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1016\/j.vaccine.2016.08.028","volume":"34","author":"BS Pickering","year":"2016","unstructured":"Pickering, B. S. et al. (2016). Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response. Vaccine, 34(40), 4777\u20134786.","journal-title":"Vaccine"},{"key":"1424_CR98","doi-asserted-by":"publisher","first-page":"108405","DOI":"10.1016\/j.vetmic.2019.108405","volume":"237","author":"E Stroh","year":"2019","unstructured":"Stroh, E. et al. (2019). Henipavirus-like particles induce a CD8 T cell response in C57BL\/6 mice. Vet Microbiol, 237, 108405.","journal-title":"Vet Microbiol"},{"issue":"1","key":"1424_CR99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/v12010026","volume":"12","author":"G Kalodimou","year":"2019","unstructured":"Kalodimou, G. et al. (2019). A soluble version of Nipah virus glycoprotein G delivered by vaccinia virus MVA activates specific CD8 and CD4 T cells in mice. Viruses, 12(1), 26.","journal-title":"Viruses"},{"key":"1424_CR100","doi-asserted-by":"publisher","unstructured":"de Vries, R. D., et al. (2020) Human paramyxovirus infections induce T cells that cross-react with zoonotic henipaviruses. Mbio, 11(4): p. https:\/\/doi.org\/10.1128\/mbio.00972-20.","DOI":"10.1128\/mbio.00972-20"},{"issue":"8","key":"1424_CR101","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2174\/1386207323666200427114343","volume":"23","author":"PKP Krishnamoorthy","year":"2020","unstructured":"Krishnamoorthy, P. K. P. et al. (2020). T-cell Epitope-based vaccine design for Nipah Virus by Reverse Vaccinology Approach. Comb Chem High Throughput Screen, 23(8), 788\u2013796.","journal-title":"Comb Chem High Throughput Screen"},{"key":"1424_CR102","first-page":"0","volume":"6","author":"V Ramasundpum","year":"2000","unstructured":"Ramasundpum, V. et al. (2000). Kinetics of IgM and IgC\u00ee seroconversion in Nipah virus infection. Malay, 6, 0.","journal-title":"Malay"},{"issue":"4","key":"1424_CR103","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche, P. A., & Furuta, K. (2015). The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol, 15(4), 203\u2013216.","journal-title":"Nat Rev Immunol"},{"key":"1424_CR104","doi-asserted-by":"publisher","unstructured":"Ademokun, A. A. and Dunn-Walters, D. (2010) Immune responses: primary and secondary. eLS. In eLS, (Ed.). https:\/\/doi.org\/10.1002\/9780470015902.a0000947.pub2.","DOI":"10.1002\/9780470015902.a0000947.pub2"},{"issue":"1","key":"1424_CR105","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri706","volume":"2","author":"D Gray","year":"2002","unstructured":"Gray, D. (2002). A role for antigen in the maintenance of immunological memory. Nat Rev Immunol, 2(1), 60\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"1424_CR106","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","volume":"121","author":"DD Taub","year":"2008","unstructured":"Taub, D. D. et al. (2008). Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med, 121(12), 1058\u20131064.","journal-title":"Am J Med"},{"issue":"6","key":"1424_CR107","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/infdis\/jiu322","volume":"210","author":"R Koepke","year":"2014","unstructured":"Koepke, R. et al. (2014). Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis, 210(6), 942\u2013953.","journal-title":"J Infect Dis"},{"key":"1424_CR108","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10875-010-9420-7","volume":"30","author":"PO Viana","year":"2010","unstructured":"Viana, P. O. et al. (2010). Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen. J Clin Immunol, 30, 574\u2013582.","journal-title":"J Clin Immunol"},{"issue":"3\u20104","key":"1424_CR109","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1865-1682.2008.01021.x","volume":"55","author":"Y Berhane","year":"2008","unstructured":"Berhane, Y. et al. (2008). Bacterial infections in pigs experimentally infected with Nipah virus. Transbound Emerg Dis, 55(3\u20104), 165\u2013174.","journal-title":"Transbound Emerg Dis"},{"key":"1424_CR110","doi-asserted-by":"crossref","unstructured":"Kany, S., J. T. Vollrath, and Relja, B. (2019). Cytokines in Inflammatory Disease. Int J Mol Sci, 20(23), 6008.","DOI":"10.3390\/ijms20236008"},{"issue":"1","key":"1424_CR111","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1121\/1.395026","volume":"81","author":"DY Fei","year":"1987","unstructured":"Fei, D. Y., Shung, K. K., & Wilson, T. M. (1987). Ultrasonic backscatter from bovine tissues: variation with pathology. J Acoust Soc Am, 81(1), 166\u2013172.","journal-title":"J Acoust Soc Am"},{"issue":"1","key":"1424_CR112","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1128\/MMBR.65.1.131-150.2001","volume":"65","author":"TH Mogensen","year":"2001","unstructured":"Mogensen, T. H., & Paludan, S. R. (2001). Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev, 65(1), 131\u2013150.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"12","key":"1424_CR113","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.3390\/v6124880","volume":"6","author":"T Schountz","year":"2014","unstructured":"Schountz, T. (2014). Immunology of bats and their viruses: challenges and opportunities. Viruses, 6(12), 4880\u20134901.","journal-title":"Viruses"},{"issue":"6","key":"1424_CR114","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000357780","volume":"21","author":"R Vazirinejad","year":"2014","unstructured":"Vazirinejad, R. et al. (2014). The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. Neuroimmunomodulation, 21(6), 322\u2013330.","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"1424_CR115","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","volume":"8","author":"EY Lee","year":"2009","unstructured":"Lee, E. Y., Lee, Z. H., & Song, Y. W. (2009). CXCL10 and autoimmune diseases. Autoimmun Rev, 8(5), 379\u2013383.","journal-title":"Autoimmun Rev"},{"key":"1424_CR116","doi-asserted-by":"crossref","unstructured":"Elemam, N. M., I. M. Talaat, and A. A. (2022) Maghazachi, CXCL10 Chemokine: A critical player in RNA and DNA viral infections. Viruses, 14(11), 2445.","DOI":"10.3390\/v14112445"},{"key":"1424_CR117","doi-asserted-by":"crossref","unstructured":"Skinner, D., Marro, B. S., & Lane, T. E. (2019). Chemokine CXCL10 and Coronavirus-induced neurologic disease. Viral Immunol, 32(1), 25\u201337.","DOI":"10.1089\/vim.2018.0073"},{"issue":"2","key":"1424_CR118","doi-asserted-by":"publisher","first-page":"e32157","DOI":"10.1371\/journal.pone.0032157","volume":"7","author":"C Mathieu","year":"2012","unstructured":"Mathieu, C. et al. (2012). Lethal Nipah virus infection induces rapid overexpression of CXCL10. PLoS One, 7(2), e32157.","journal-title":"PLoS One"},{"issue":"5","key":"1424_CR119","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S0002-9440(10)63714-5","volume":"164","author":"Y Sui","year":"2004","unstructured":"Sui, Y. et al. (2004). Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol, 164(5), 1557\u20131566.","journal-title":"Am J Pathol"},{"issue":"4","key":"1424_CR120","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1460-9568.2006.04631.x","volume":"23","author":"Y Sui","year":"2006","unstructured":"Sui, Y. et al. (2006). CXCL10\u2010induced cell death in neurons: role of calcium dysregulation. Eur J Neurosci, 23(4), 957\u2013964.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1424_CR121","doi-asserted-by":"publisher","first-page":"e1008412","DOI":"10.1371\/journal.ppat.1008412","volume":"16","author":"AP Woon","year":"2020","unstructured":"Woon, A. P. et al. (2020). Acute experimental infection of bats and ferrets with Hendra virus: Insights into the early host response of the reservoir host and susceptible model species. PLoS Pathog, 16(3), e1008412.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1424_CR122","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.virol.2013.03.004","volume":"441","author":"M Gupta","year":"2013","unstructured":"Gupta, M., Lo, M. K., & Spiropoulou, C. F. (2013). Activation and cell death in human dendritic cells infected with Nipah virus. Virology, 441(1), 49\u201356.","journal-title":"Virology"},{"issue":"5","key":"1424_CR123","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","volume":"25","author":"SM Stamatovic","year":"2005","unstructured":"Stamatovic, S. M. et al. (2005). Monocyte chemoattractant protein-1 regulation of blood\u2013brain barrier permeability. J Cereb Blood Flow Metab, 25(5), 593\u2013606.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Supplement_4","key":"1424_CR124","doi-asserted-by":"publisher","first-page":"S436","DOI":"10.1093\/infdis\/jiz613","volume":"221","author":"AN Prasad","year":"2020","unstructured":"Prasad, A. N. et al. (2020). Resistance of cynomolgus monkeys to Nipah and Hendra virus disease is associated with cell-mediated and humoral immunity. J Infect Dis, 221(Supplement_4), S436\u2013S447.","journal-title":"J Infect Dis"},{"issue":"1","key":"1424_CR125","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4049\/jimmunol.175.1.413","volume":"175","author":"EL Levroney","year":"2005","unstructured":"Levroney, E. L. et al. (2005). Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J Immunol, 175(1), 413\u2013420.","journal-title":"J Immunol"},{"key":"1424_CR126","doi-asserted-by":"crossref","unstructured":"Mari\u00e9, I., Durbin, J. E., & Levy, D. E. (1998). Differential viral induction of distinct interferon\u2010\u03b1 genes by positive feedback through interferon regulatory factor\u20107. EMBO J, 6660-9.","DOI":"10.1093\/emboj\/17.22.6660"},{"issue":"10","key":"1424_CR127","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1128\/JVI.79.10.6078-6088.2005","volume":"79","author":"ML Shaw","year":"2005","unstructured":"Shaw, M. L. et al. (2005). Nuclear localization of the Nipah virus W protein allows for inhibition of both virus-and toll-like receptor 3-triggered signaling pathways. J Virol, 79(10), 6078\u20136088.","journal-title":"J Virol"},{"issue":"12","key":"1424_CR128","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/nbt1363","volume":"25","author":"WA Marasco","year":"2007","unstructured":"Marasco, W. A., & Sui, J. (2007). The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol, 25(12), 1421\u20131434.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"1424_CR129","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","volume":"21","author":"G Pantaleo","year":"2022","unstructured":"Pantaleo, G. et al. (2022). Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discov, 21(9), 676\u2013696.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1424_CR130","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/immuno3020011","volume":"3","author":"B Brown","year":"2023","unstructured":"Brown, B. et al. (2023). Immunopathogenesis of Nipah virus infection and associated immune responses. Immuno, 3(2), 160\u2013181.","journal-title":"Immuno"},{"issue":"242","key":"1424_CR131","doi-asserted-by":"publisher","first-page":"242ra82","DOI":"10.1126\/scitranslmed.3008929","volume":"6","author":"TW Geisbert","year":"2014","unstructured":"Geisbert, T. W. et al. (2014). Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med, 6(242), 242ra82.","journal-title":"Sci Transl Med"},{"issue":"4","key":"1424_CR132","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1473-3099(19)30634-6","volume":"20","author":"EG Playford","year":"2020","unstructured":"Playford, E. G. et al. (2020). Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect Dis, 20(4), 445\u2013454.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"1424_CR133","doi-asserted-by":"publisher","first-page":"S471","DOI":"10.1093\/infdis\/jiz515","volume":"221","author":"CE Mire","year":"2020","unstructured":"Mire, C. E. et al. (2020). A cross-reactive humanized monoclonal antibody targeting fusion glycoprotein function protects ferrets against lethal Nipah Virus and Hendra Virus infection. J Infect Dis, 221(Suppl 4), S471\u2013S479.","journal-title":"J Infect Dis"},{"issue":"4","key":"1424_CR134","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1128\/JVI.80.4.1972-1978.2006","volume":"80","author":"V Guillaume","year":"2006","unstructured":"Guillaume, V. et al. (2006). Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol, 80(4), 1972\u20131978.","journal-title":"J Virol"},{"issue":"10","key":"1424_CR135","doi-asserted-by":"publisher","first-page":"e1000642","DOI":"10.1371\/journal.ppat.1000642","volume":"5","author":"KN Bossart","year":"2009","unstructured":"Bossart, K. N. et al. (2009). A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog, 5(10), e1000642.","journal-title":"PLoS Pathog"},{"key":"1424_CR136","doi-asserted-by":"publisher","first-page":"74","DOI":"10.12703\/r\/10-74","volume":"10","author":"K Johnson","year":"2021","unstructured":"Johnson, K. et al. (2021). Recent advances in combating Nipah virus. Fac Rev, 10, 74.","journal-title":"Fac Rev"},{"issue":"6","key":"1424_CR137","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/528801","volume":"197","author":"Z Zhu","year":"2008","unstructured":"Zhu, Z. et al. (2008). Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis, 197(6), 846\u2013853.","journal-title":"J Infect Dis"},{"issue":"22","key":"1424_CR138","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122769119","volume":"119","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. (2022). Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant. Proc Natl Acad Sci USA, 119(22), e2122769119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1424_CR139","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tim.2015.07.005","volume":"23","author":"M Pelegrin","year":"2015","unstructured":"Pelegrin, M. et al. (2015). Antiviral monoclonal antibodies: can they be more than simple neutralizing agents? Trends Microbiol, 23(10), 653\u2013665.","journal-title":"Trends Microbiol"},{"key":"1424_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-237","volume":"10","author":"JA Pallister","year":"2013","unstructured":"Pallister, J. A. et al. (2013). Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virol J, 10, 237.","journal-title":"Virol J"},{"key":"1424_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-353","volume":"10","author":"CE Mire","year":"2013","unstructured":"Mire, C. E. et al. (2013). Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virol J, 10, 353.","journal-title":"Virol J"},{"key":"1424_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1387811","volume":"15","author":"C Yin","year":"2024","unstructured":"Yin, C. et al. (2024). A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus. Front Immunol, 15, 1387811.","journal-title":"Front Immunol"},{"issue":"6","key":"1424_CR143","doi-asserted-by":"publisher","first-page":"e0007462","DOI":"10.1371\/journal.pntd.0007462","volume":"13","author":"N van Doremalen","year":"2019","unstructured":"van Doremalen, N. et al. (2019). A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters. PLoS Negl Trop Dis, 13(6), e0007462.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1424_CR144","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/JVI.02308-14","volume":"89","author":"D Kurup","year":"2015","unstructured":"Kurup, D. et al. (2015). Rhabdovirus-based vaccine platforms against henipaviruses. J Virol, 89(1), 144\u2013154.","journal-title":"J Virol"},{"issue":"6","key":"1424_CR145","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1021\/acsabm.4c00441","volume":"7","author":"VH Leyva-Grado","year":"2024","unstructured":"Leyva-Grado, V. H. et al. (2024). Nano-assembled polyphosphazene delivery system enables effective intranasal immunization with Nipah virus subunit vaccine. ACS Appl bio Mater, 7(6), 4133\u20134141.","journal-title":"ACS Appl bio Mater"},{"issue":"12","key":"1424_CR146","doi-asserted-by":"publisher","first-page":"e0011851","DOI":"10.1371\/journal.pntd.0011851","volume":"17","author":"S Watanabe","year":"2023","unstructured":"Watanabe, S. et al. (2023). Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8. PLoS Negl Trop Dis, 17(12), e0011851.","journal-title":"PLoS Negl Trop Dis"},{"key":"1424_CR147","doi-asserted-by":"crossref","unstructured":"Bhattacharya, M. et al. (2022) Therapeutic role of neutralizing antibody for the treatment against SARS-CoV-2 and its emerging variants: a clinical and pre-clinical perspective. Vaccines, 10(10), 1612.","DOI":"10.3390\/vaccines10101612"},{"key":"1424_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-042420-113838","volume":"73","author":"D Li","year":"2022","unstructured":"Li, D. et al. (2022). SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment. Annu Rev Med, 73, 1\u201316.","journal-title":"Annu Rev Med"},{"issue":"5","key":"1424_CR149","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41594-021-00584-8","volume":"28","author":"HV Dang","year":"2021","unstructured":"Dang, H. V. et al. (2021). Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nat Struct Mol Biol, 28(5), 426\u2013434.","journal-title":"Nat Struct Mol Biol"},{"issue":"6587","key":"1424_CR150","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.abm5561","volume":"375","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. (2022). Architecture and antigenicity of the Nipah virus attachment glycoprotein. Science, 375(6587), 1373\u20131378.","journal-title":"Science"},{"issue":"7","key":"1424_CR151","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jiph.2023.05.010","volume":"16","author":"C Chakraborty","year":"2023","unstructured":"Chakraborty, C. et al. (2023). Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses. J Infect public health, 16(7), 1048\u20131056.","journal-title":"J Infect public health"},{"issue":"1","key":"1424_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25780-3","volume":"8","author":"BE Dawes","year":"2018","unstructured":"Dawes, B. E. et al. (2018). Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci Rep., 8(1), 7604.","journal-title":"Sci Rep."},{"issue":"9186","key":"1424_CR153","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(99)04379-2","volume":"354","author":"NI Paton","year":"1999","unstructured":"Paton, N. I. et al. (1999). Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet, 354(9186), 1253\u20131256.","journal-title":"Lancet"},{"issue":"6","key":"1424_CR154","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.arcmed.2020.05.001","volume":"51","author":"A Saha","year":"2020","unstructured":"Saha, A. et al. (2020). Probable molecular mechanism of Remdesivir for the Treatment of COVID-19: Need to know more. Arch Med Res, 51(6), 585\u2013586.","journal-title":"Arch Med Res"},{"issue":"1","key":"1424_CR155","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00162-20","volume":"34","author":"JJ Malin","year":"2020","unstructured":"Malin, J. J. et al. (2020). Remdesivir against COVID-19 and other viral diseases. Clin Microbiol Rev, 34(1), e00162-20.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1424_CR156","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.arcmed.2020.09.005","volume":"52","author":"A Saha","year":"2021","unstructured":"Saha, A. et al. (2021). Response to: Status of Remdesivir: Not yet beyond question! Arch Med Res, 52(1), 104\u2013106.","journal-title":"Arch Med Res"},{"issue":"494","key":"1424_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau9242","volume":"11","author":"MK Lo","year":"2019","unstructured":"Lo, M. K. et al. (2019). Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Sci Transl Med, 11(494), eaau9242.","journal-title":"Sci Transl Med"},{"issue":"Suppl 4","key":"1424_CR158","doi-asserted-by":"publisher","first-page":"S395","DOI":"10.1093\/infdis\/jiz455","volume":"221","author":"M Elvert","year":"2020","unstructured":"Elvert, M. et al. (2020). Cytokine induction in Nipah virus-infected primary human and Porcine Bronchial epithelial cells. J Infect Dis, 221(Suppl 4), S395\u2013S400.","journal-title":"J Infect Dis"},{"issue":"1","key":"1424_CR159","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1586\/14787210.4.1.57","volume":"4","author":"Z Zhu","year":"2006","unstructured":"Zhu, Z. et al. (2006). Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Expert Rev Anti-infect Ther, 4(1), 57\u201366.","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"39","key":"1424_CR160","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1016\/j.vaccine.2021.08.027","volume":"39","author":"B Nikolay","year":"2021","unstructured":"Nikolay, B. et al. (2021). Assessing the feasibility of Nipah vaccine efficacy trials based on previous outbreaks in Bangladesh. Vaccine, 39(39), 5600\u20135606.","journal-title":"Vaccine"},{"issue":"2","key":"1424_CR161","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/imm.13695","volume":"171","author":"G Mishra","year":"2024","unstructured":"Mishra, G. et al. (2024). Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics. Immunology, 171(2), 155\u2013169.","journal-title":"Immunology"},{"key":"1424_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0023-7","volume":"2","author":"P Walpita","year":"2017","unstructured":"Walpita, P. et al. (2017). A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. NPJ Vaccines, 2, 21.","journal-title":"NPJ Vaccines"},{"issue":"1","key":"1424_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00588-5","volume":"7","author":"DG Ithinji","year":"2022","unstructured":"Ithinji, D. G. et al. (2022). Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses. NPJ Vaccines, 7(1), 166 17.","journal-title":"NPJ Vaccines"},{"issue":"16","key":"1424_CR164","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1128\/JVI.00263-06","volume":"80","author":"HM Weingartl","year":"2006","unstructured":"Weingartl, H. M. et al. (2006). Recombinant nipah virus vaccines protect pigs against challenge. J Virol, 80(16), 7929\u20137938.","journal-title":"J Virol"},{"key":"1424_CR165","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.ppat.1010658","volume":"18","author":"Monath","year":"2022","unstructured":"Monath, & Thomas, P. et al. (2022). Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. PLoS Pathog, 18, 6\u2013e1010658.","journal-title":"PLoS Pathog"},{"issue":"3","key":"1424_CR166","doi-asserted-by":"publisher","first-page":"e58414","DOI":"10.1371\/journal.pone.0058414","volume":"8","author":"M Yoneda","year":"2013","unstructured":"Yoneda, M. et al. (2013). Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PloS one, 8(3), e58414.","journal-title":"PloS one"},{"issue":"6","key":"1424_CR167","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13205-015-0303-8","volume":"5","author":"M Kamthania","year":"2015","unstructured":"Kamthania, M., & Sharma, D. K. (2015). Screening and structure-based modeling of T-cell epitopes of Nipah virus proteome: an immunoinformatic approach for designing peptide-based vaccine. 3 Biotech, 5(6), 877\u2013882.","journal-title":"3 Biotech"},{"key":"1424_CR168","doi-asserted-by":"crossref","unstructured":"Sakib, M. S. et al. (2014). Prediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of Nipah virus using in silico approach. Adv Bioinformatics: 402492.","DOI":"10.1155\/2014\/402492"},{"issue":"6","key":"1424_CR169","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.apjtm.2017.06.016","volume":"10","author":"CK Saha","year":"2017","unstructured":"Saha, C. K. et al. (2017). In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses. Asian Pac J Trop Med, 10(6), 529\u2013538.","journal-title":"Asian Pac J Trop Med"},{"issue":"5","key":"1424_CR170","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1002\/jcb.27979","volume":"120","author":"L Ravichandran","year":"2019","unstructured":"Ravichandran, L. et al. (2019). Epitope-based immunoinformatics approach on RNA-dependent RNA polymerase (RdRp) protein complex of Nipah virus (NiV). J Cell Biochem, 120(5), 7082\u20137095.","journal-title":"J Cell Biochem"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01424-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01424-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01424-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:09:28Z","timestamp":1732036168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01424-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":170,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01424-4","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"10 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}